A Study of Efgartigimod in Patients With IgG4-Related Disease
Clinical trial NCT07025330 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07025330
- Sponsor
- Stanford University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-12
- Primary completion
- 2028-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.